Thermo Fisher Scientific Inc (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 11,122,000 | 10,855,000 | 10,364,000 | 11,395,000 | 10,598,000 |
| Cost of Goods | 6,539,000 | 6,446,000 | 6,129,000 | 6,573,000 | 6,270,000 |
| Gross Profit | 4,583,000 | 4,409,000 | 4,235,000 | 4,822,000 | 4,328,000 |
| Operating Expenses | 2,643,000 | 2,574,000 | 2,518,000 | 2,805,000 | 2,489,000 |
| Operating Income | 1,941,000 | 1,834,000 | 1,716,000 | 2,016,000 | 1,838,000 |
| Interest Expense | 347,000 | 404,000 | 303,000 | 317,000 | 356,000 |
| Other Income | 234,000 | 281,000 | 193,000 | 275,000 | 246,000 |
| Pre-tax Income | 1,828,000 | 1,711,000 | 1,606,000 | 1,974,000 | 1,728,000 |
| Income Tax | 207,000 | 92,000 | 95,000 | 149,000 | 99,000 |
| Net Income Continuous | 1,621,000 | 1,619,000 | 1,511,000 | 1,825,000 | 1,629,000 |
| Minority Interests | 5,000 | 2,000 | 4,000 | -7,000 | N/A |
| Net Income | $1,616,000 | $1,616,000 | $1,507,000 | $1,832,000 | $1,629,000 |
| EPS Basic Total Ops | 4.28 | 4.28 | 3.99 | 4.80 | 4.26 |
| EPS Basic Continuous Ops | 4.29 | 4.28 | 4.00 | 4.78 | 4.26 |
| EPS Diluted Total Ops | 4.27 | 4.28 | 3.98 | 4.78 | 4.25 |
| EPS Diluted Continuous Ops | 4.29 | 4.28 | 3.99 | 4.79 | 4.24 |
| EPS Diluted Before Non-Recurring Items | 5.79 | 5.36 | 5.15 | 6.10 | 5.28 |
| EBITDA(a) | $2,601,000 | $2,521,000 | $2,422,000 | $2,759,000 | $2,578,000 |